3np2: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal Structure of Pd(allyl)/apo-E45C/C48A-rHLFr== | ==Crystal Structure of Pd(allyl)/apo-E45C/C48A-rHLFr== | ||
<StructureSection load='3np2' size='340' side='right' caption='[[3np2]], [[Resolution|resolution]] 1.86Å' scene=''> | <StructureSection load='3np2' size='340' side='right'caption='[[3np2]], [[Resolution|resolution]] 1.86Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[3np2]] is a 1 chain structure with sequence from [ | <table><tr><td colspan='2'>[[3np2]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Equus_caballus Equus caballus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NP2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3NP2 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=PD:PALLADIUM+ION'>PD</scene>, <scene name='pdbligand=PLL:PALLADIUM(II)+ALLYL+COMPLEX'>PLL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.86Å</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CD:CADMIUM+ION'>CD</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=PD:PALLADIUM+ION'>PD</scene>, <scene name='pdbligand=PLL:PALLADIUM(II)+ALLYL+COMPLEX'>PLL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3np2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3np2 OCA], [https://pdbe.org/3np2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3np2 RCSB], [https://www.ebi.ac.uk/pdbsum/3np2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3np2 ProSAT]</span></td></tr> | |||
</table> | </table> | ||
== Function == | |||
[https://www.uniprot.org/uniprot/FRIL_HORSE FRIL_HORSE] Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity). | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 14: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
<div class="pdbe-citations 3np2" style="background-color:#fffaf0;"></div> | |||
==See Also== | ==See Also== | ||
*[[Ferritin|Ferritin]] | *[[Ferritin 3D structures|Ferritin 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 22: | Line 27: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Equus caballus]] | [[Category: Equus caballus]] | ||
[[Category: Abe | [[Category: Large Structures]] | ||
[[Category: Aoyagi | [[Category: Abe S]] | ||
[[Category: Hikage | [[Category: Aoyagi H]] | ||
[[Category: Kitagawa | [[Category: Hikage T]] | ||
[[Category: Takezawa | [[Category: Kitagawa S]] | ||
[[Category: Ueno | [[Category: Takezawa Y]] | ||
[[Category: Wang | [[Category: Ueno T]] | ||
[[Category: Watanabe | [[Category: Wang Z]] | ||
[[Category: Watanabe Y]] | |||
Latest revision as of 19:49, 1 November 2023
Crystal Structure of Pd(allyl)/apo-E45C/C48A-rHLFrCrystal Structure of Pd(allyl)/apo-E45C/C48A-rHLFr
Structural highlights
FunctionFRIL_HORSE Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity). Publication Abstract from PubMedApo-ferritin (apo-Fr) mutants are used as scaffolds to accommodate palladium (allyl) complexes. Various coordination arrangements of the Pd complexes are achieved by adjusting the positions of cysteine and histidine residues on the interior surface of the apo-Fr cage. Definite coordination arrangement of organometallic palladium complexes accumulated on the designed interior surface of apo-ferritin.,Wang Z, Takezawa Y, Aoyagi H, Abe S, Hikage T, Watanabe Y, Kitagawa S, Ueno T Chem Commun (Camb). 2011 Jan 7;47(1):170-2. Epub 2010 Aug 23. PMID:20730233[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||